Cimpress plc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $3.7B+9.8% YoYTTM through 30 Jun 2026
Net Income $95.9M+541.2% YoYTTM through 30 Jun 2026
Free Cash Flow $183.5MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 46.2% |
| EBITDA Margin | 10.8% |
| Operating Margin | 5.6% |
| Net Margin | 2.6% |
Returns
-19.4%ROE
4.4%ROA
11.0%ROIC
Balance Sheet Health
Debt / Equity-3.26x
Current Ratio0.68x
Net Debt$1.6B
Cash & Equivalents$248.9M
Quality Metrics
Altman Z-Score2.58
Piotroski F-Score8 / 9
FCF Margin4.9%
Rule of 4012.2
Earnings-Beat Rate75.0%
Multi-Year Trend
RevenueFY2026: $3.7B
Diluted EPS$3.79TTMFY2026: $3.79
Dividend
No dividend
Capital Allocation
R&D Spend$68.6M
Capex Intensity2.7%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| Vista | +7.0% | ||
| Upload & Print | +26.0% | ||
| National Pen | +10.0% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.